Back to Royal Bank of Canada Royal Bank of Canada

MCRBMCRB

Showing 4 of 24 quarters

Position history for Royal Bank of CanadaRoyal Bank of Canada's holdings in Seres Therapeutics, Inc.

As of its Q1 2025 13F, Royal Bank of Canada held 4,444 shares of MCRB (Seres Therapeutics), worth $3,000. Royal Bank of Canada's 13F filings listed MCRB from Q3 2019 to Q1 2025, 23 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

$0

Total Shares Change

-132

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$11.11
0
2025-Q1
Increased
4,444
+126.6%
$3,0000.0%$14.00
14
2024-Q4
Increased
1,961
+1385.6%
$2,0000.0%$16.62
12
2024-Q3
Decreased
132
-97.2%
$00.0%$18.38
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used